Loading the content... Loading depends on your connection speed!

Enter New Email
Confirm New Email
Enter Old Password
Enter New Password
Confirm New Password
 
Email sent successfully to:
Evaluation
 

Identifying Patients at Risk for Irinotecan (Camptosar) Myelotoxicity Based on UGT1A1 Genotype
Processing...

MyLikes

MyPaths

Info
Algorithm Information

Identifying Patients at Risk for Irinotecan (Camptosar) Myelotoxicity Based on UGT1A1 Genotype

MyLikes

MyPaths
Purpose:
To evaluate a patient with colorectal adenocarcinoma for therapy with irinotecan (Camptosar) therapy based on UGT1A1 enzyme activity.
Specialty
  • Toxicology
    Emergency Medicine
    Critical Care
    Genetics
Objective
  • Risk factors
  • Selection
ICD-10
  • T45.1
References
Interpretation and Description
Share this Algorithm
MyPaths
Cancel
Create Path
Create
Cancel
Create Note
Save
Identifying Patients at Risk for Irinotecan (Camptosar) Myelotoxicity Based on UGT1A1 Genotype
Cancel
Save Data
Save
Limitation to 5 characters is for patient privacy.